Go Pro

Oaktree Specialty Lending (OCSL) Financials

Oaktree Specialty Lending logo
$12.99 -0.12 (-0.92%)
As of 08/21/2026 04:00 PM Eastern
Annual Income Statements for Oaktree Specialty Lending

Annual Income Statements for Oaktree Specialty Lending

This table shows Oaktree Specialty Lending's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders
237 29 119 58 37
Consolidated Net Income / (Loss)
241 33 117 58 34
Net Income / (Loss) Continuing Operations
241 33 181 58 153
Total Pre-Tax Income
241 33 181 58 154
Total Revenue
320 97 268 136 201
Net Interest Income / (Expense)
160 203 268 238 201
Total Interest Income
174 229 379 346 317
Investment Securities Interest Income
191 249 379 361 317
Total Interest Expense
31 47 112 129 116
Long-Term Debt Interest Expense
31 47 112 129 116
Total Non-Interest Income
159 -106 0.00 -103 0.00
Total Non-Interest Expense
79 64 85 78 45
Insurance Policy Acquisition Costs
39 18 36 30 7.15
Other Operating Expenses
40 46 49 48 38
Income Tax Expense
- - 0.00 - 0.86
Other Adjustments to Consolidated Net Income / (Loss)
- - -63 - -119
Basic Earnings per Share
$4.39 $0.48 $1.63 $0.72 $0.39
Weighted Average Basic Shares Outstanding
54.04M 60.73M 72.12M 80.42M 86.08M
Diluted Earnings per Share
$4.39 $0.48 $1.63 $0.72 $0.39
Weighted Average Diluted Shares Outstanding
54.04M 60.73M 72.12M 80.42M 86.08M
Weighted Average Basic & Diluted Shares Outstanding
- - 77.23M 82.25M 88.09M

Quarterly Income Statements for Oaktree Specialty Lending

This table shows Oaktree Specialty Lending's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
11 9.34 1.12 37 7.84 -36 38 27 5.61 -19 31
Consolidated Net Income / (Loss)
11 9.51 1.32 36 7.24 -36 39 24 5.64 -19 31
Net Income / (Loss) Continuing Operations
11 9.51 1.32 36 44 -37 39 143 5.64 -19 31
Total Pre-Tax Income
11 9.51 1.32 36 45 -37 39 144 5.64 -19 31
Total Revenue
32 30 19 54 56 18 49 114 17 -8.19 44
Net Interest Income / (Expense)
63 58 60 58 56 -27 43 131 44 43 43
Total Interest Income
95 85 86 80 87 1.57 74 162 71 69 67
Investment Securities Interest Income
93 89 91 89 87 - 73 - 70 68 66
Deposits and Money Market Investments Interest Income
2.36 1.49 1.16 0.98 - 1.57 1.51 - 0.93 1.05 0.86
Total Interest Expense
32 32 33 32 31 28 31 26 27 26 24
Long-Term Debt Interest Expense
32 32 33 32 31 - 31 - 27 26 24
Total Non-Interest Income
-31 -28 -40 -3.63 0.00 45 5.95 -17 -27 -51 1.26
Other Service Charges
1.31 2.55 1.46 3.90 - 3.48 0.29 - 2.97 1.30 0.98
Net Realized & Unrealized Capital Gains on Investments
-26 -34 -44 -4.39 - -36 3.20 - -31 -55 -2.86
Other Non-Interest Income
-6.41 3.66 2.51 -3.13 - - 2.46 - 1.47 2.70 3.15
Total Non-Interest Expense
22 21 18 18 11 55 11 -32 12 10 12
Insurance Policy Acquisition Costs
9.03 8.45 5.13 7.72 1.54 - 0.41 - 1.19 0.00 2.37
Other Operating Expenses
13 12 13 9.99 9.39 55 10 -38 11 10 10
Basic Earnings per Share
$0.14 $0.12 $0.01 $0.46 $0.09 ($0.42) $0.44 $0.28 $0.06 ($0.21) $0.35
Weighted Average Basic Shares Outstanding
77.84M 79.76M 81.83M 80.42M 82.25M 85.92M 88.09M 86.08M 88.09M 88.09M 88.09M
Diluted Earnings per Share
$0.14 $0.12 $0.01 $0.46 $0.09 ($0.42) $0.44 $0.28 $0.06 ($0.21) $0.35
Weighted Average Diluted Shares Outstanding
77.84M 79.76M 81.83M 80.42M 82.25M 85.92M 88.09M 86.08M 88.09M 88.09M 88.09M
Weighted Average Basic & Diluted Shares Outstanding
78.97M 81.40M 82.25M 82.25M 82.25M 88.09M 88.09M 88.09M 88.09M 88.09M 88.09M

Annual Cash Flow Statements for Oaktree Specialty Lending

This table details how cash moves in and out of Oaktree Specialty Lending's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Change in Cash & Equivalents
-7.46 -5.27 119 -67 1.09
Net Cash From Operating Activities
-231 22 229 19 228
Net Cash From Continuing Operating Activities
-231 22 229 19 228
Net Income / (Loss) Continuing Operations
237 29 117 58 34
Consolidated Net Income / (Loss)
237 29 117 58 34
Depreciation Expense
-115 136 29 -19 101
Amortization Expense
-25 -25 -17 -12 -8.19
Non-Cash Adjustments to Reconcile Net Income
-350 -47 207 -80 84
Changes in Operating Assets and Liabilities, net
21 -71 -107 72 17
Net Cash From Investing Activities
0.00 0.00 0.44 0.00 0.00
Net Cash From Continuing Investing Activities
0.00 0.00 0.44 0.00 0.00
Other Investing Activities, net
- 0.00 0.44 - 0.00
Net Cash From Financing Activities
224 -27 -110 -87 -229
Net Cash From Continuing Financing Activities
224 -27 -110 -87 -229
Issuance of Debt
854 300 869 255 800
Issuance of Common Equity
0.00 21 1.37 93 103
Repayment of Debt
-548 -230 -798 -256 -973
Repurchase of Common Equity
-2.17 -1.86 -2.42 -1.55 -11
Payment of Dividends
-80 -115 -180 -177 -148
Other Financing Activities, Net
0.00 -0.22 -0.24 -0.12 -0.04
Effect of Exchange Rate Changes
-1.13 -0.85 0.83 0.70 2.06
Cash Interest Paid
24 39 98 122 110

Quarterly Cash Flow Statements for Oaktree Specialty Lending

This table details how cash moves in and out of Oaktree Specialty Lending's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-14 5.80 -30 -29 48 -18 -28 -0.17 1.18 -30 -11
Net Cash From Operating Activities
1.13 -18 -60 96 144 62 21 1.34 -83 131 58
Net Cash From Continuing Operating Activities
1.13 -18 -60 96 144 62 21 1.34 -83 131 58
Net Income / (Loss) Continuing Operations
11 9.34 1.12 37 7.24 -36 38 25 5.61 -19 31
Consolidated Net Income / (Loss)
11 9.34 1.12 37 7.24 -36 38 25 5.61 -19 31
Depreciation Expense
25 25 -26 -43 20 82 -19 18 32 39 -48
Amortization Expense
-3.77 -1.37 -2.14 -4.37 -3.28 -2.91 1.20 -3.20 -2.28 -2.01 -1.66
Non-Cash Adjustments to Reconcile Net Income
-138 -50 -44 157 162 -122 102 -58 -134 148 73
Changes in Operating Assets and Liabilities, net
107 -0.58 12 -51 -42 142 -102 19 15 -36 3.27
Net Cash From Financing Activities
-15 23 30 -125 -95 -82 -52 -0.23 85 -160 -69
Net Cash From Continuing Financing Activities
-15 23 30 -125 -95 -82 -52 -0.23 85 -160 -69
Issuance of Debt
20 50 135 50 125 500 80 95 225 60 75
Repayment of Debt
-20 -30 -76 -130 -175 -644 -95 -60 -105 -185 -114
Repurchase of Common Equity
0.00 - - -1.55 -1.46 -4.29 -3.75 -1.17 -1.14 -1.14 -1.08
Payment of Dividends
-47 -43 -43 -44 -44 -37 -33 -34 -34 -34 -29
Effect of Exchange Rate Changes
-0.32 0.31 -0.24 0.96 -1.15 2.13 2.35 -1.27 -0.13 0.04 0.05
Cash Interest Paid
28 33 28 34 28 30 28 25 26 26 23

Annual Balance Sheets for Oaktree Specialty Lending

This table presents Oaktree Specialty Lending's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Total Assets
2,646 3,218 3,198 3,003
Cash and Due from Banks
24 136 64 80
Trading Account Securities
2.47 4.91 3,021 2,853
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00
Accrued Investment Income
36 45 39 32
Customer and Other Receivables
22 6.32 13 3.19
Deferred Acquisition Cost
7.38 13 12 9.82
Other Assets
54 3,004 35 22
Total Liabilities & Shareholders' Equity
2,646 3,218 3,198 3,003
Total Liabilities
1,401 1,702 1,711 1,537
Short-Term Debt
700 710 710 545
Accrued Interest Payable
7.94 16 16 12
Long-Term Debt
601 891 929 942
Other Long-Term Liabilities
92 85 43 31
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,246 1,516 1,488 1,466
Total Preferred & Common Equity
1,246 1,516 1,488 1,466
Total Common Equity
1,246 1,516 1,488 1,466
Common Stock
1,828 2,167 2,265 2,351
Retained Earnings
-583 -651 -777 -885

Quarterly Balance Sheets for Oaktree Specialty Lending

This table presents Oaktree Specialty Lending's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2023 6/30/2023 12/31/2023 3/31/2024 6/30/2024 12/31/2024 3/31/2025 6/30/2025 12/31/2025 3/31/2026 6/30/2026
Total Assets
3,319 3,336 3,266 3,298 3,322 3,084 3,079 2,964 3,098 2,894 2,858
Cash and Due from Banks
44 60 112 125 96 113 98 80 81 51 40
Trading Account Securities
0.00 0.05 3,020 3,061 3,136 2,845 2,896 2,809 2,957 2,774 2,741
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income
29 29 43 37 28 25 23 23 24 23 23
Customer and Other Receivables
2.02 2.08 7.91 1.80 0.95 0.41 0.32 0.30 0.30 0.30 0.24
Deferred Acquisition Cost
7.23 13 12 11 12 11 10 10 9.29 8.60 8.07
Other Assets
3,228 105 53 63 52 79 45 33 27 37 39
Total Liabilities & Shareholders' Equity
3,319 3,336 3,266 3,298 3,322 3,084 3,079 2,964 3,098 2,894 2,858
Total Liabilities
1,803 1,827 1,755 1,774 1,826 1,634 1,604 1,488 1,662 1,512 1,475
Short-Term Debt
1,115 1,135 710 730 790 660 520 510 665 540 501
Accrued Interest Payable
15 13 19 16 19 18 14 12 12 10 11
Long-Term Debt
609 605 913 906 907 918 928 938 945 942 938
Other Long-Term Liabilities
65 74 85 122 76 39 141 28 36 15 16
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,515 1,509 1,512 1,524 1,496 1,450 1,475 1,476 1,436 1,382 1,383
Total Preferred & Common Equity
1,515 1,509 1,512 1,524 1,496 1,450 1,475 1,476 1,436 1,382 1,383
Total Common Equity
1,515 1,509 1,512 1,524 1,496 1,450 1,475 1,476 1,436 1,382 1,383
Common Stock
2,164 2,164 2,201 2,249 2,265 2,265 2,368 2,368 2,351 2,351 2,351
Retained Earnings
-649 -655 -690 -725 -769 -815 -893 -892 -915 -969 -968

Annual Metrics And Ratios for Oaktree Specialty Lending

This table displays calculated financial ratios and metrics derived from Oaktree Specialty Lending's official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Growth Metrics
- - - - -
Revenue Growth
0.00% -69.82% 113.35% -34.06% 47.99%
EBITDA Growth
0.00% 42.09% -9.57% -79.29% 821.17%
EBIT Growth
0.00% -86.36% 262.10% -51.43% 170.07%
NOPAT Growth
0.00% -86.36% 262.10% -51.43% 164.10%
Net Income Growth
0.00% -86.36% 262.10% -51.43% -41.31%
EPS Growth
0.00% -86.36% 239.58% -55.83% -45.83%
Operating Cash Flow Growth
0.00% 109.72% 921.49% -91.66% 1,097.17%
Free Cash Flow Firm Growth
0.00% 0.00% 82.06% 110.60% 583.12%
Invested Capital Growth
0.00% 0.00% 22.38% 0.32% -5.56%
Revenue Q/Q Growth
0.00% 0.00% 135.60% -10.62% 42.61%
EBITDA Q/Q Growth
0.00% 0.00% 172.48% -59.82% 225.49%
EBIT Q/Q Growth
0.00% 0.00% 2,444.09% -16.90% 239.17%
NOPAT Q/Q Growth
0.00% 0.00% 787.50% -16.90% 231.67%
Net Income Q/Q Growth
0.00% 0.00% 35.51% -16.90% -26.77%
EPS Q/Q Growth
0.00% 0.00% 68.04% -12.20% -26.42%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 346.65% -88.60% -29.20%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -84.13% 3.54%
Invested Capital Q/Q Growth
0.00% 0.00% 1,245.54% 0.00% 0.98%
Profitability Metrics
- - - - -
EBITDA Margin
31.79% 149.64% 63.42% 19.92% 123.97%
EBIT Margin
75.31% 34.04% 57.78% 42.56% 77.67%
Profit (Net Income) Margin
75.31% 34.04% 57.78% 42.56% 16.88%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 22.10%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 98.34%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.56%
Return on Invested Capital (ROIC)
0.00% 2.58% 4.20% 1.85% 5.02%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 2.58% 4.20% 1.85% -2.58%
Return on Net Nonoperating Assets (RNNOA)
0.00% 2.70% 4.42% 2.00% -2.72%
Return on Equity (ROE)
0.00% 5.28% 8.62% 3.85% 2.30%
Cash Return on Invested Capital (CROIC)
0.00% -197.42% -15.92% 1.53% 10.74%
Operating Return on Assets (OROA)
0.00% 1.24% 4.06% 1.80% 5.03%
Return on Assets (ROA)
0.00% 1.24% 4.06% 1.80% 1.09%
Return on Common Equity (ROCE)
0.00% 5.28% 8.62% 3.85% 2.30%
Return on Equity Simple (ROE_SIMPLE)
0.00% 2.64% 7.85% 3.88% 2.31%
Net Operating Profit after Tax (NOPAT)
241 33 119 58 153
NOPAT Margin
75.31% 34.04% 57.78% 42.56% 75.96%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.00% 7.60%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
24.69% 65.96% 42.22% 57.44% 22.33%
Earnings before Interest and Taxes (EBIT)
241 33 119 58 156
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
102 144 131 27 249
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
0.00 0.00 0.85 0.84 0.78
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.85 0.84 0.78
Price to Revenue (P/Rev)
0.00 0.00 6.25 9.26 5.72
Price to Earnings (P/E)
0.00 0.00 10.97 21.71 31.49
Dividend Yield
10.47% 14.88% 13.11% 14.40% 14.10%
Earnings Yield
0.00% 0.00% 9.12% 4.61% 3.18%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.88 0.90 0.87
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 13.32 20.75 12.72
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 21.00 104.16 10.26
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 23.05 48.74 16.38
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 23.05 48.74 16.75
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 11.99 147.68 11.20
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 58.95 7.83
Leverage & Solvency
- - - - -
Debt to Equity
0.00 1.04 1.06 1.10 1.01
Long-Term Debt to Equity
0.00 0.48 0.59 0.62 0.64
Financial Leverage
0.00 1.04 1.05 1.08 1.06
Leverage Ratio
0.00 2.12 2.12 2.14 2.10
Compound Leverage Factor
0.00 2.12 2.12 2.14 2.06
Debt to Total Capital
0.00% 51.09% 51.36% 52.41% 50.36%
Short-Term Debt to Total Capital
0.00% 27.49% 22.78% 22.71% 18.46%
Long-Term Debt to Total Capital
0.00% 23.60% 28.58% 29.70% 31.90%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 48.91% 48.64% 47.59% 49.64%
Debt to EBITDA
0.00 9.01 12.26 60.59 5.97
Net Debt to EBITDA
0.00 8.83 11.14 57.69 5.65
Long-Term Debt to EBITDA
0.00 4.16 6.82 34.34 3.78
Debt to NOPAT
0.00 39.59 13.45 28.35 9.74
Net Debt to NOPAT
0.00 38.79 12.23 26.99 9.22
Long-Term Debt to NOPAT
0.00 18.29 7.49 16.07 6.17
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - -
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 -2,514 -451 48 326
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 -53.56 -4.04 0.37 2.82
Operating Cash Flow to Interest Expense
-7.55 0.48 2.05 0.15 1.97
Operating Cash Flow Less CapEx to Interest Expense
-7.55 0.48 2.05 0.15 1.97
Efficiency Ratios
- - - - -
Asset Turnover
0.00 0.04 0.07 0.04 0.06
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - -
Invested Capital
0.00 2,547 3,116 3,127 2,953
Invested Capital Turnover
0.00 0.08 0.07 0.04 0.07
Increase / (Decrease) in Invested Capital
0.00 2,547 570 10 -174
Enterprise Value (EV)
0.00 0.00 2,742 2,817 2,557
Market Capitalization
0.00 0.00 1,287 1,257 1,150
Book Value per Share
$0.00 $20.51 $19.66 $18.09 $16.64
Tangible Book Value per Share
$0.00 $20.51 $19.66 $18.09 $16.64
Total Capital
0.00 2,547 3,116 3,127 2,953
Total Debt
0.00 1,301 1,601 1,639 1,487
Total Long-Term Debt
0.00 601 891 929 942
Net Debt
0.00 1,275 1,455 1,560 1,407
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
0.00 0.00 0.00 0.00 119
Net Nonoperating Obligations (NNO)
0.00 1,301 1,601 1,639 1,487
Total Depreciation and Amortization (D&A)
-139 112 12 -31 93
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.63 $0.72 $0.39
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 72.12M 80.42M 86.08M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.63 $0.72 $0.39
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 72.12M 80.42M 86.08M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $2.51 $2.18 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 77.23M 82.25M 88.09M
Normalized Net Operating Profit after Tax (NOPAT)
169 23 83 40 153
Normalized NOPAT Margin
52.72% 23.83% 40.45% 29.79% 75.96%
Pre Tax Income Margin
75.31% 34.04% 57.78% 42.56% 76.39%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
7.89 0.70 1.07 0.45 1.35
NOPAT to Interest Expense
7.89 0.70 1.07 0.45 1.32
EBIT Less CapEx to Interest Expense
7.89 0.70 1.07 0.45 1.35
NOPAT Less CapEx to Interest Expense
7.89 0.70 1.07 0.45 1.32
Payout Ratios
- - - - -
Dividend Payout Ratio
33.15% 350.72% 151.32% 305.92% 436.91%
Augmented Payout Ratio
34.06% 356.38% 153.35% 308.61% 468.35%

Quarterly Metrics And Ratios for Oaktree Specialty Lending

This table displays calculated financial ratios and metrics derived from Oaktree Specialty Lending's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 88,085,523.00 88,085,523.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 88,085,523.00 88,085,523.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - -0.21 0.36
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.19% -31.32% -67.71% -23.01% -40.75% -39.12% 157.03% 111.28% -69.05% -144.41% -10.91%
EBITDA Growth
1.56% -7.81% -179.61% -139.01% -25.00% 27.44% 178.85% 1,527.21% -41.81% -55.95% -186.24%
EBIT Growth
-15.15% -55.94% -96.40% -24.48% -28.66% -484.24% 2,825.64% 303.62% -87.50% 49.16% -18.57%
NOPAT Growth
-15.15% -55.94% -96.40% -24.48% -28.66% -368.97% 2,825.64% 296.48% -87.26% 49.16% -18.57%
Net Income Growth
-15.15% -55.94% -96.40% -24.48% -28.66% -481.09% 2,825.64% -34.21% -22.03% 48.74% -18.57%
EPS Growth
-36.36% -58.62% -97.92% -28.13% -35.71% -450.00% 4,300.00% -39.13% -33.33% 50.00% -20.45%
Operating Cash Flow Growth
101.02% -138.16% -223.07% -60.82% 12,696.09% 451.89% 135.17% -98.60% -157.97% 110.77% 173.07%
Free Cash Flow Firm Growth
211.06% 102.76% 101.79% 105.03% -1,388.83% 137.22% 435.27% 1,110.01% 99.57% -77.74% -56.61%
Invested Capital Growth
0.00% -2.45% -1.73% 0.32% 0.00% -7.47% -8.43% -5.56% 0.61% -2.05% -3.49%
Revenue Q/Q Growth
-53.86% -6.32% -36.62% 181.03% -64.49% -3.76% 167.61% 131.01% -84.77% -147.17% 636.88%
EBITDA Q/Q Growth
10.36% 4.47% -180.90% 58.18% 312.15% 77.53% -49.95% 657.08% -77.81% -47.61% -197.99%
EBIT Q/Q Growth
-77.69% -11.19% -86.10% 2,642.21% -78.92% -578.33% 205.82% 278.32% -96.14% -429.23% 269.49%
NOPAT Q/Q Growth
-77.69% -11.19% -86.10% 2,642.21% -78.92% -434.83% 251.17% 271.62% -96.07% -330.46% 342.13%
Net Income Q/Q Growth
-77.69% -11.19% -86.10% 2,642.21% -78.92% -574.40% 206.70% -38.33% -76.34% -429.23% 269.49%
EPS Q/Q Growth
-78.13% -14.29% -91.67% 4,500.00% -80.43% -566.67% 204.76% -36.36% -78.57% -450.00% 266.67%
Operating Cash Flow Q/Q Growth
-99.54% -1,666.22% -240.17% 259.35% 50.73% -56.93% -66.00% -93.67% -6,351.09% 256.60% -55.95%
Free Cash Flow Firm Q/Q Growth
191.96% -62.12% -35.18% -88.73% -598.04% 106.97% 46.26% 3.11% -104.08% 461.85% 185.04%
Invested Capital Q/Q Growth
-100.00% 0.00% 1.06% 0.00% 0.00% -3.44% 0.01% 0.98% 3.17% -5.99% -1.46%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
98.86% 110.25% -140.73% -20.94% 125.12% 230.81% 43.17% 141.48% 206.12% 0.00% -41.79%
EBIT Margin
33.12% 31.40% 6.89% 67.19% 39.88% -198.19% 78.37% 128.35% 32.51% 0.00% 71.64%
Profit (Net Income) Margin
33.12% 31.40% 6.89% 67.19% 39.88% -196.57% 78.37% 20.92% 32.51% 0.00% 71.64%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 99.18% 100.00% 16.59% 100.00% 100.00% 100.00%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.23% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 1.89% 0.32% 2.92% 3.23% -5.05% 3.61% 8.34% 1.74% 0.00% 3.25%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 1.89% 0.32% 2.92% 3.23% -5.74% 3.61% 0.66% 1.74% 0.00% 3.25%
Return on Net Nonoperating Assets (RNNOA)
0.00% 2.08% 0.37% 3.15% 3.52% -5.91% 3.82% 0.70% 1.92% 0.00% 3.28%
Return on Equity (ROE)
0.00% 3.97% 0.70% 6.07% 6.75% -10.96% 7.43% 9.04% 3.66% 0.00% 6.52%
Cash Return on Invested Capital (CROIC)
0.00% 5.76% 3.90% 1.53% -196.38% 8.05% 10.31% 10.74% 3.16% 6.65% 7.92%
Operating Return on Assets (OROA)
0.00% 1.82% 0.31% 2.84% 1.59% -6.88% 3.51% 8.32% 1.71% 0.00% 3.20%
Return on Assets (ROA)
0.00% 1.82% 0.31% 2.84% 1.59% -6.83% 3.51% 1.36% 1.71% 0.00% 3.20%
Return on Common Equity (ROCE)
0.00% 3.97% 0.70% 6.07% 6.75% -10.96% 7.43% 9.04% 3.66% 0.00% 6.52%
Return on Equity Simple (ROE_SIMPLE)
0.00% 6.89% 4.65% 0.00% 3.77% 0.61% 3.14% 0.00% 2.25% 3.62% 3.10%
Net Operating Profit after Tax (NOPAT)
11 9.51 1.32 36 7.64 -26 39 144 5.64 -13 31
NOPAT Margin
33.12% 31.40% 6.89% 67.19% 39.88% -138.74% 78.37% 126.08% 32.51% 0.00% 71.64%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.69% 0.00% 7.67% 0.00% 0.38% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
66.88% 68.60% 93.11% 32.81% 60.12% 298.19% 21.63% -28.35% 67.49% 0.00% 28.36%
Earnings before Interest and Taxes (EBIT)
11 9.51 1.32 36 7.64 -37 39 146 5.64 -19 31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
32 33 -27 -11 24 43 21 161 36 19 -18
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.90 0.93 0.84 0.87 0.86 0.81 0.78 0.78 0.72 0.76
Price to Tangible Book Value (P/TBV)
0.00 0.90 0.93 0.84 0.87 0.86 0.81 0.78 0.78 0.72 0.76
Price to Revenue (P/Rev)
6.75 7.11 9.13 9.26 10.25 11.41 8.54 5.72 6.92 7.34 8.08
Price to Earnings (P/E)
12.12 13.33 20.72 21.71 23.01 140.01 26.01 31.49 32.73 19.27 23.78
Dividend Yield
12.22% 12.71% 12.91% 14.40% 14.40% 13.80% 14.57% 14.10% 13.27% 14.34% 0.00%
Earnings Yield
8.25% 7.50% 4.83% 4.61% 4.35% 0.71% 3.84% 3.18% 3.05% 5.19% 4.21%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.91 0.93 0.90 0.89 0.89 0.88 0.87 0.87 0.85 0.87
Enterprise Value to Revenue (EV/Rev)
0.00 14.91 19.59 20.75 22.09 23.51 18.25 12.72 16.34 17.89 18.82
Enterprise Value to EBITDA (EV/EBITDA)
0.00 22.33 44.22 104.16 142.16 92.27 33.59 10.26 11.87 12.15 15.32
Enterprise Value to EBIT (EV/EBIT)
0.00 27.28 42.80 48.74 49.49 300.43 55.87 16.38 22.74 18.03 19.24
Enterprise Value to NOPAT (EV/NOPAT)
0.00 27.28 42.80 48.74 49.49 300.43 55.87 16.75 23.14 18.30 19.55
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 10.38 17.79 147.68 16.73 10.78 7.97 11.20 2,747.58 34.83 23.09
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 15.55 23.67 58.95 0.00 10.64 8.15 7.83 27.62 12.61 10.77
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 1.07 1.13 1.10 1.09 0.98 0.98 1.01 1.12 1.07 1.04
Long-Term Debt to Equity
0.00 0.59 0.61 0.62 0.63 0.63 0.64 0.64 0.66 0.68 0.68
Financial Leverage
0.00 1.11 1.14 1.08 1.09 1.03 1.06 1.06 1.10 1.03 1.01
Leverage Ratio
0.00 2.18 2.22 2.14 2.13 2.13 2.11 2.10 2.14 2.09 2.04
Compound Leverage Factor
0.00 2.18 2.22 2.14 2.13 2.13 2.11 2.06 2.14 2.09 2.04
Debt to Total Capital
0.00% 51.77% 53.15% 52.41% 52.11% 49.54% 49.51% 50.36% 52.85% 51.74% 50.99%
Short-Term Debt to Total Capital
0.00% 23.10% 24.74% 22.71% 21.80% 17.79% 17.44% 18.46% 21.83% 18.86% 17.75%
Long-Term Debt to Total Capital
0.00% 28.66% 28.41% 29.70% 30.31% 31.76% 32.06% 31.90% 31.02% 32.88% 33.23%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 48.23% 46.85% 47.59% 47.89% 50.46% 50.49% 49.64% 47.15% 48.26% 49.01%
Debt to EBITDA
0.00 12.75 25.21 60.59 82.82 51.33 18.91 5.97 7.21 7.42 9.00
Net Debt to EBITDA
0.00 11.68 23.62 57.69 76.20 47.50 17.87 5.65 6.84 7.17 8.75
Long-Term Debt to EBITDA
0.00 7.06 13.48 34.34 48.17 32.91 12.25 3.78 4.23 4.72 5.86
Debt to NOPAT
0.00 15.58 24.40 28.35 28.83 167.15 31.45 9.74 14.05 11.18 11.48
Net Debt to NOPAT
0.00 14.27 22.86 26.99 26.53 154.66 29.72 9.22 13.35 10.79 11.16
Long-Term Debt to NOPAT
0.00 8.63 13.04 16.07 16.77 107.14 20.37 6.17 8.25 7.10 7.48
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
234 89 58 26 -3,020 211 308 318 -13 47 134
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
7.28 2.78 1.77 0.82 -98.81 7.47 9.91 12.20 -0.49 1.83 5.54
Operating Cash Flow to Interest Expense
0.04 -0.55 -1.84 2.98 4.71 2.20 0.68 0.05 -3.13 5.10 2.38
Operating Cash Flow Less CapEx to Interest Expense
0.04 -0.55 -1.84 2.98 4.71 2.20 0.68 0.05 -3.13 5.10 2.38
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.06 0.05 0.04 0.04 0.03 0.04 0.06 0.05 0.05 0.04
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 3,160 3,193 3,127 3,028 2,924 2,924 2,953 3,046 2,864 2,822
Invested Capital Turnover
0.00 0.06 0.05 0.04 0.08 0.04 0.05 0.07 0.05 0.05 0.05
Increase / (Decrease) in Invested Capital
-224 -79 -56 10 3,028 -236 -269 -174 19 -60 -102
Enterprise Value (EV)
0.00 2,865 2,977 2,817 2,708 2,604 2,571 2,557 2,651 2,426 2,451
Market Capitalization
1,391 1,367 1,387 1,257 1,257 1,263 1,203 1,150 1,122 995 1,052
Book Value per Share
$0.00 $19.30 $18.38 $18.09 $17.63 $17.94 $16.76 $16.64 $16.30 $15.69 $15.70
Tangible Book Value per Share
$0.00 $19.30 $18.38 $18.09 $17.63 $17.94 $16.76 $16.64 $16.30 $15.69 $15.70
Total Capital
0.00 3,160 3,193 3,127 3,028 2,924 2,924 2,953 3,046 2,864 2,822
Total Debt
0.00 1,636 1,697 1,639 1,578 1,448 1,448 1,487 1,610 1,482 1,439
Total Long-Term Debt
0.00 906 907 929 918 928 938 942 945 942 938
Net Debt
0.00 1,498 1,590 1,560 1,452 1,340 1,368 1,407 1,529 1,430 1,399
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
0.00 0.00 0.00 0.00 0.00 11 0.00 120 0.00 5.57 0.00
Net Nonoperating Obligations (NNO)
0.00 1,636 1,697 1,639 1,578 1,448 1,448 1,487 1,610 1,482 1,439
Total Depreciation and Amortization (D&A)
21 24 -28 -48 16 79 -17 15 30 37 -50
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.14 $0.12 $0.01 $0.46 $0.09 ($0.42) $0.44 $0.28 $0.06 ($0.21) $0.35
Adjusted Weighted Average Basic Shares Outstanding
77.84M 79.76M 81.83M 80.42M 82.25M 85.92M 88.09M 86.08M 88.09M 88.09M 88.09M
Adjusted Diluted Earnings per Share
$0.14 $0.12 $0.01 $0.46 $0.09 ($0.42) $0.44 $0.28 $0.06 ($0.21) $0.35
Adjusted Weighted Average Diluted Shares Outstanding
77.84M 79.76M 81.83M 80.42M 82.25M 85.92M 88.09M 86.08M 88.09M 88.09M 88.09M
Adjusted Basic & Diluted Earnings per Share
$0.57 $0.52 $0.54 $0.46 $0.54 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
78.97M 162.79M 82.25M 82.25M 82.25M 88.09M 88.09M 88.09M 88.09M 88.09M 88.09M
Normalized Net Operating Profit after Tax (NOPAT)
7.50 6.66 0.93 25 5.35 -26 27 101 3.95 -13 22
Normalized NOPAT Margin
23.19% 21.98% 4.82% 47.03% 27.91% -138.74% 54.86% 88.25% 22.76% 0.00% 50.15%
Pre Tax Income Margin
33.12% 31.40% 6.89% 67.19% 39.88% -198.19% 78.37% 126.08% 32.51% 0.00% 71.64%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.33 0.30 0.04 1.13 0.25 -1.30 1.25 5.62 0.21 -0.73 1.30
NOPAT to Interest Expense
0.33 0.30 0.04 1.13 0.25 -0.91 1.25 5.52 0.21 -0.51 1.30
EBIT Less CapEx to Interest Expense
0.33 0.30 0.04 1.13 0.25 -1.30 1.25 5.62 0.21 -0.73 1.30
NOPAT Less CapEx to Interest Expense
0.33 0.30 0.04 1.13 0.25 -0.91 1.25 5.52 0.21 -0.51 1.30
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
145.43% 163.83% 250.26% 305.92% 317.27% 1,872.43% 340.71% 436.91% 428.51% 271.04% 306.29%
Augmented Payout Ratio
145.43% 164.90% 250.26% 308.61% 322.76% 1,953.79% 364.56% 468.35% 460.52% 285.44% 316.87%

Financials Breakdown Chart

Key Financial Trends

Oaktree Specialty Lending (NASDAQ: OCSL) showed a sharp rebound in profitability in the most recent quarter, but the longer trend still points to a highly volatile earnings profile. For Q2 2026, the company posted a net loss of $18.9 million, or $0.21 per share, after reporting a $5.6 million profit in Q1 2026. That swing was driven largely by a big negative mark on investments, which pushed total revenue back into negative territory despite solid net interest income.

What stands out over the last several years is the inconsistency in OCSL’s non-interest income and investment gains/losses. In several quarters, the company generated healthy net interest income, but gains and losses on investments regularly overwhelmed that strength. That makes quarterly results harder to predict and helps explain why profitability has bounced between strong gains and meaningful losses.

Cash flow remains a relative strength. Even in Q2 2026, OCSL produced $130.7 million of operating cash flow, which helped offset the quarterly loss. However, financing outflows were substantial because the company paid $34.1 million in dividends and $185.0 million in debt repayments, resulting in a net cash decline of $29.6 million. The business is still capable of generating cash, but capital deployment and debt management remain important moving parts.

The balance sheet shows moderate leverage and some improvement in equity, but not without pressure. Total assets fell from $3.10 billion in Q1 2026 to $2.89 billion in Q2 2026, while total liabilities declined from $1.66 billion to $1.51 billion. Total common equity also slipped from $1.44 billion to $1.38 billion. Debt remains significant, with $540 million of short-term debt and $941.7 million of long-term debt at the end of Q2 2026.

  • Operating cash flow was strong in Q2 2026 at $130.7 million.
  • Net interest income remained positive at $43.1 million in Q2 2026, showing the core lending spread is still producing earnings power.
  • Total liabilities declined quarter over quarter in Q2 2026, suggesting some balance sheet de-risking.
  • Cash and equivalents improved sequentially from Q1 2026 to Q2 2026, rising from $80.8 million to $51.3 million after the quarter’s activities, although the ending level was still modest relative to debt.
  • The company has continued paying dividends, which remains attractive for income-focused investors.
  • Results continue to depend heavily on investment marks, which can swing earnings sharply from quarter to quarter.
  • Total assets have remained near the $2.9 billion to $3.3 billion range over the past four years, indicating a fairly stable asset base.
  • Share count has been relatively controlled, with weighted average shares staying around 88 million in recent quarters.
  • Q2 2026 produced a net loss of $18.9 million after a profitable Q1, highlighting ongoing earnings volatility.
  • Debt remains elevated, including $1.48 billion of total debt obligations when short-term and long-term borrowings are combined.

Looking at the multi-year trend, OCSL has had periods of strong profitability, but the pattern has been uneven. In FY2024 and parts of FY2025, the company produced sizable quarterly profits, including Q4 2025’s $27.2 million of income attributable to common shareholders and Q1 2026’s $5.6 million profit. But those gains have been interrupted by weak quarters and occasional losses, especially when capital gains and portfolio marks turn negative.

Bottom line: OCSL looks like a cash-generating specialty lender with meaningful dividend support and a fairly sizable asset base, but investors should expect volatility. The main positives are operating cash flow and recurring net interest income. The main risks are leverage, heavy dividend obligations, and the outsized impact of investment valuation changes on reported earnings.

08/23/26 03:49 AM ETAI Generated. May Contain Errors.

Oaktree Specialty Lending Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Oaktree Specialty Lending's financial year ends in September. Their financial year 2025 ended on September 30, 2025.

Oaktree Specialty Lending's net income appears to be on a downward trend, with a most recent value of $33.92 million in 2025, falling from $240.84 million in 2021. The previous period was $57.80 million in 2024. See Oaktree Specialty Lending's forecast for analyst expectations on what's next for the company.

Over the last 4 years, Oaktree Specialty Lending's total revenue changed from $319.81 million in 2021 to $200.96 million in 2025, a change of -37.2%.

Oaktree Specialty Lending's total liabilities were at $1.54 billion at the end of 2025, a 10.1% decrease from 2024, and a 9.7% increase since 2022.

In the past 3 years, Oaktree Specialty Lending's cash and equivalents has ranged from $23.53 million in 2022 to $136.45 million in 2023, and is currently $79.63 million as of their latest financial filing in 2025.

Over the last 4 years, Oaktree Specialty Lending's book value per share changed from 0.00 in 2021 to 16.64 in 2025, a change of 1,664.1%.



Financial statements for NASDAQ:OCSL last updated on 8/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners